Media ReleasesNoxopharm

View All Noxopharm News


Noxopharm, Open Briefing Presentation - December 6, 2017

Oncology

NOX66 Idronoxil (lipophilic form)

ABOUT IDRONOXIL

Multiple anti-cancer actions

1. Inhibits DNA repair (inhibits PARP-1, topoisomerases 1 and 2)

2. Promotes anti-tumour immunity (Increases NK (natural killer) cell activity)


To view Presentation please download PDF attached:
Download this document